Design, synthesis and evaluation of potential inhibitors of HIV gp120–CD4 interactions
作者:Cyrille Boussard、Thomas Klimkait、Naheed Mahmood、Martin Pritchard、Ian H. Gilbert
DOI:10.1016/j.bmcl.2004.02.091
日期:2004.5
This paper describes an approach to prevent HIV-cell fusion by disrupting the interaction between HIV protein gp120 and CD4 receptor. The CD4 residues Phe43 and Arg59 make important interactions with gp120. Small molecule analogues were made to mimic the crucial features of these residues. The analogues were assayed using a cellular 'FIGS' assay to measure inhibition of cell fusion and caused some inhibition. (C) 2004 Elsevier Ltd. All rights reserved.
US7396844B1
申请人:——
公开号:US7396844B1
公开(公告)日:2008-07-08
BENZAMIDINE DERIVATIVES
申请人:Ajinomoto Co., Inc.
公开号:EP0976722B1
公开(公告)日:2009-03-11
Benzamidine derivatives
申请人:Ajinomoto Co., Inc.
公开号:US07396844B1
公开(公告)日:2008-07-08
Benzamidine derivatives of the following formulae or analogs thereof, i.e., pharmaceutically acceptable salts thereof, are provided. These compounds or salts thereof have a blood-coagulation inhibiting effect based on an excellent effect of inhibiting the action of activated blood coagulation factor X, and they are useful as anticoagulants